Search Results - "Terrien, Edward F"

White Line Sign of Impending Coronary Occlusion in Transcatheter Aortic Valve Replacement by Rambod, Mehdi, Terrien, Edward F, Dauerman, Harold L

Get full text

Two hour bivalirudin infusion after PCI for ST elevation myocardial infarction by Anderson, Phillip R., Gogo, Prospero B., Ahmed, Bina, Straight, Faye, Terrien, Edward F., Watkins, Matthew W., El Gharib, Nader, Dauerman, Harold L.

“…The standard of care for STEMI PCI for the past decade has been aspirin, clopidogrel, heparin, and a glycoprotein IIbIIIa receptor inhibitor (GPI). A…”
Get full text

Rescue of Threatened Coronary Obstruction Due to Sinus Sequestration: Valve-in-Valve Transcatheter Aortic Valve Replacement by Kadavath, Sabeeda M, Terrien, Edward F, Ittleman, Frank P, Lahoud, Rony, Phuong, Newton P, Dauerman, Harold L

Get full text

Usefulness of platelet reactivity before percutaneous coronary intervention in determining cardiac risk one year later by Kabbani, Samer S., Watkins, Matthew W., Ashikaga, Taka, Terrien, Edward F., Sobel, Burton E., Schneider, David J.

“…Research results demonstrate that flow cytometric analysis of platelet function in patients who undergo percutaneous coronary intervention (PCI) can stratify…”
Get full text

Relation of Leukocytosis to C-Reactive Protein and Interleukin-6 Among Patients Undergoing Percutaneous Coronary Intervention by Gogo, Prospero B., Schneider, David J., Terrien, Edward F., Watkins, Matthew W., Sobel, Burton E., Dauerman, Harold L.

“…An elevated white blood cell (WBC) count and elevated C-reactive protein (CRP) have been associated with an increased risk of adverse cardiac events. The…”
Get full text

Platelet reactivity characterized prospectively: A determinant of outcome 90 days after percutaneous coronary intervention by KABBANI, Samer S, WATKINS, Matthew W, ASHIKAGA, Taka, TERRIEN, Edward F, HOLOCH, Peter A, SOBEL, Burton E, SCHNEIDER, David J

“…Platelet activation is pivotal in the pathogenesis of complications after percutaneous coronary interventions (PCI). We previously reported substantial…”
Get full text

Suboptimal early inhibition of platelets by treatment with tirofiban and implications for coronary interventions by Kabbani, Samer S, Aggarwal, Atul, Terrien, Edward F, DiBattiste, Peter M, Sobel, Burton E, Schneider, David J

“…The present study was designed to identify potential causes for the lower incidence of complications after percutaneous coronary intervention in patients…”
Get full text

Increased coronary arterial release of interleukin-1 receptor antagonist and soluble CD40 ligand indicative of inflammation associated with culprit coronary plaques by Aggarwal, Atul, Schneider, David J, Terrien, Edward F, Sobel, Burton E, Dauerman, Harold L

“…Blood taken from the coronary artery ostium reflects biochemical changes indicative of thrombosis in the culprit vessel. We sought to determine whether…”
Get full text

Systemic inflammation after drug-eluting stent placement by Gogo, Jr, Prospero B, Schneider, David J, Watkins, Matthew W, Terrien, Edward F, Sobel, Burton E, Dauerman, Harold L

“…Systemic inflammation after coronary intervention identifies patients at increased risk of subsequent cardiac events. Cardiac events are less frequent after…”
Get full text

Comparison of effects of abciximab versus eptifibatide on C-reactive protein, interleukin-6, and interleukin-1 receptor antagonist after coronary arterial stenting by Aggarwal, Atul, Schneider, David J., Terrien, Edward F., Terrien, Christopher M., Sobel, Burton E., Dauerman, Harold L.

“…Concentrations of high-sensitivity C-reactive protein, interleukin-6 and interleukin-1 receptor antagonist were determined after coronary stenting in 50…”
Get full text

Increase in interleukin-6 in the first hour after coronary stenting: An early marker of the inflammatory response by AGGARWAL, Atul, SCHNEIDER, David J, TERRIEN, Edward F, GILBERT, Kristin E, DAUERMAN, Harold L

“…Inflammation after coronary stenting presages adverse outcomes after percutaneous coronary intervention (PCI). While changes in inflammatory markers have been…”
Get full text

Extravascular closure for patients with high-risk femoral anatomy by Rashid, Mitchell N, Ahmed, Bina, Straight, Faye, Bradley, Jason T, Gilbert, Kristin, Gogo, Prospero B, Terrien, Edward F, Watkins, Matthew W, Dauerman, Harold L

“…Vascular closure devices (VCDs) improve patient comfort and decrease time to ambulation. However, VCD studies have excluded patients with high-risk femoral…”
Get more information

Osteoprotegerin is not associated with angiographic coronary calcification by Gogo, Jr, Prospero B, Schneider, David J, Terrien, Edward F, Sobel, Burton E, Dauerman, Harold L

“…Coronary artery calcification may play a significant role in the pathophysiology of plaque progression and healing. We hypothesized that osteoprotegerin, an…”
Get full text

Rescue of Threatened Coronary Obstruction Due to Sinus Sequestration by Kadavath, Sabeeda M., Terrien, Edward F., Ittleman, Frank P., Lahoud, Rony, Phuong, Newton P., Dauerman, Harold L.

Get full text

Treatment of totally occluded saphenous vein grafts using self-expanding stents by Aggarwal, Atul, Terrien, Edward F, Terrien, Christopher M

“…Patients with saphenous vein graft (SVG) disease represent an increasing proportion of those referred for percutaneous coronary intervention. The success of…”
Get full text

Platelet reactivity in Coronary ostial blood: A reflection of the thrombotic state accompanying plaque rupture and of the adequacy of anti-thrombotic therapy by KABBANI, Samer S, WATKINS, Matthew W, HOLOCH, Peter A, TERRIEN, Edward F, SOBEL, Burton E, SCHNEIDER, David J

“…Optimal anti-thrombotic therapy for acute coronary syndromes (ACS) should suppress pro-thrombotic activity at the site of plaque rupture. We sought to…”
Get full text

Enhanced suppression of inflammation after coronary stenting (ESIS): A randomized clinical trial comparing Abciximab and eptifibatide by Aggarwal, Atul, Schneider, David J., Terrien, Edward F., Terrien, Christopher M., Watkins, Matthew W., Kabbani, Samer S., Dauerman, Harold L.

Get full text

Increased concentrations of interleukin-1 receptor antagonist associated with diabetes mellitus and in the vicinity of coronary plaques: A sensitive marker of inflammation by Aggarwal, Atul, Schneider, David J., Terrien, Edward F., Whitaker, Deborah A., Sobel, Burton E., Dauerman, Harold L.

Get full text

Platelet reactivity characterized prospectively: A determinant of outcome 90 days after percutaneous coronary interention by Kabbani, Samer S, Watkins, Matthew W, Ashikaga, Taka, Terrien, Edward F

“…BACKGROUND: Platelet activation is pivotal in the pathogenesis of complications after percutaneous coronary interventions (PCI). We previously reported…”
Get full text

Effect of reperfusion modality on outcome in nonsmokers and smokers with acute myocardial infarction (a Primary Angioplasty in Myocardial Infarction (PAMI) substudy) by Bowers, Terry R, Terrien, Edward F, O Neill, William W, Sachs, Debra

“…Nonsmokers with acute myocardial infarction represent a group with more advanced cardiac risk factors and underlying atherosclerosis. A study found that the…”
Get full text